Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07018037
Role of TTV During First-line Immunotherapy Treatment in Patients With Renal Cell Carcinoma
Sponsor: Regina Elena Cancer Institute
View on ClinicalTrials.gov
Summary
The aim of this project is to descriptively explore the trend of torquetenovirus viral load TTV during therapy with immune checkpoint inhibitor ICI in these patients, to evaluate a possible role of this virus as a biomarker of response.
Official title: Pilot Study to Describe the Role of TTV During First-line Immunotherapy Treatment in Patients With Renal Cell Carcinoma
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
20
Start Date
2025-01-29
Completion Date
2027-01-29
Last Updated
2025-06-12
Healthy Volunteers
No
Conditions
Locations (1)
"Regina Elena" National Cancer Institute
Rome, Italy